Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine model
Hepatitis-B vaccine (HBVv) can prevent HBV-infection and associated liver diseases. However, concerns regarding its safety, particularly among patients with autoimmune diseases (i.e. SLE) were raised. Moreover, the aluminum adjuvant in HBVv was related to immune mediated adverse events. Therefore, w...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2014
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/22257
- Acceso en línea:
- https://doi.org/10.1016/j.jaut.2014.06.006
https://repository.urosario.edu.co/handle/10336/22257
- Palabra clave:
- Aluminum hydroxide
Double stranded dna antibody
Hepatitis b surface antigen
Immunological adjuvant
Phosphate buffered saline
Recombinant hepatitis b vaccine
Antinuclear antibody
Hepatitis b vaccine
Animal experiment
Animal model
Animal tissue
Antibody titer
Anxiety
Article
Autoimmune disease
Blood cell count
Brain histology
Brain region
Cell lineage
Cognition
Controlled study
Disease exacerbation
Drug safety
Erythrocyte
Female
Forced swim test
Gliosis
Immunization
Kidney disease
Lupus like syndrome
Memory disorder
Microglia
Mouse
Nonhuman
Novel object recognition test
Proteinuria
Staircase test
Systemic lupus erythematosus
Y-maze test
Animal
Brain
Disease model
Drug effects
Immunology
Lupus erythematosus nephritis
Pathology
Pathophysiology
Animals
Brain
Cognition
Female
Hepatitis b vaccines
Lupus nephritis
Mice
Proteinuria
Autoimmune/autoinflammatory syndrome induced by adjuvant (asia)
Autoimmunity
Hepatitis b vaccine
Neuro-cognitive tests
Sle
Vaccination
animal
antinuclear
Antibodies
Disease models
- Rights
- License
- Abierto (Texto Completo)
id |
EDOCUR2_9344cd78f184c666faf7adaa67954aba |
---|---|
oai_identifier_str |
oai:repository.urosario.edu.co:10336/22257 |
network_acronym_str |
EDOCUR2 |
network_name_str |
Repositorio EdocUR - U. Rosario |
repository_id_str |
|
dc.title.spa.fl_str_mv |
Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine model |
title |
Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine model |
spellingShingle |
Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine model Aluminum hydroxide Double stranded dna antibody Hepatitis b surface antigen Immunological adjuvant Phosphate buffered saline Recombinant hepatitis b vaccine Antinuclear antibody Hepatitis b vaccine Animal experiment Animal model Animal tissue Antibody titer Anxiety Article Autoimmune disease Blood cell count Brain histology Brain region Cell lineage Cognition Controlled study Disease exacerbation Drug safety Erythrocyte Female Forced swim test Gliosis Immunization Kidney disease Lupus like syndrome Memory disorder Microglia Mouse Nonhuman Novel object recognition test Proteinuria Staircase test Systemic lupus erythematosus Y-maze test Animal Brain Disease model Drug effects Immunology Lupus erythematosus nephritis Pathology Pathophysiology Animals Brain Cognition Female Hepatitis b vaccines Lupus nephritis Mice Proteinuria Autoimmune/autoinflammatory syndrome induced by adjuvant (asia) Autoimmunity Hepatitis b vaccine Neuro-cognitive tests Sle Vaccination animal antinuclear Antibodies Disease models |
title_short |
Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine model |
title_full |
Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine model |
title_fullStr |
Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine model |
title_full_unstemmed |
Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine model |
title_sort |
Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine model |
dc.subject.keyword.spa.fl_str_mv |
Aluminum hydroxide Double stranded dna antibody Hepatitis b surface antigen Immunological adjuvant Phosphate buffered saline Recombinant hepatitis b vaccine Antinuclear antibody Hepatitis b vaccine Animal experiment Animal model Animal tissue Antibody titer Anxiety Article Autoimmune disease Blood cell count Brain histology Brain region Cell lineage Cognition Controlled study Disease exacerbation Drug safety Erythrocyte Female Forced swim test Gliosis Immunization Kidney disease Lupus like syndrome Memory disorder Microglia Mouse Nonhuman Novel object recognition test Proteinuria Staircase test Systemic lupus erythematosus Y-maze test Animal Brain Disease model Drug effects Immunology Lupus erythematosus nephritis Pathology Pathophysiology Animals Brain Cognition Female Hepatitis b vaccines Lupus nephritis Mice Proteinuria Autoimmune/autoinflammatory syndrome induced by adjuvant (asia) Autoimmunity Hepatitis b vaccine Neuro-cognitive tests Sle Vaccination |
topic |
Aluminum hydroxide Double stranded dna antibody Hepatitis b surface antigen Immunological adjuvant Phosphate buffered saline Recombinant hepatitis b vaccine Antinuclear antibody Hepatitis b vaccine Animal experiment Animal model Animal tissue Antibody titer Anxiety Article Autoimmune disease Blood cell count Brain histology Brain region Cell lineage Cognition Controlled study Disease exacerbation Drug safety Erythrocyte Female Forced swim test Gliosis Immunization Kidney disease Lupus like syndrome Memory disorder Microglia Mouse Nonhuman Novel object recognition test Proteinuria Staircase test Systemic lupus erythematosus Y-maze test Animal Brain Disease model Drug effects Immunology Lupus erythematosus nephritis Pathology Pathophysiology Animals Brain Cognition Female Hepatitis b vaccines Lupus nephritis Mice Proteinuria Autoimmune/autoinflammatory syndrome induced by adjuvant (asia) Autoimmunity Hepatitis b vaccine Neuro-cognitive tests Sle Vaccination animal antinuclear Antibodies Disease models |
dc.subject.keyword.eng.fl_str_mv |
animal antinuclear Antibodies Disease models |
description |
Hepatitis-B vaccine (HBVv) can prevent HBV-infection and associated liver diseases. However, concerns regarding its safety, particularly among patients with autoimmune diseases (i.e. SLE) were raised. Moreover, the aluminum adjuvant in HBVv was related to immune mediated adverse events. Therefore, we examined the effects of immunization with HBVv or alum on SLE-like disease in a murine model.NZBWF1 mice were immunized with HBVv (Engerix), or aluminum hydroxide (alum) or phosphate buffered saline (PBS) at 8 and 12 weeks of age. Mice were followed for weight, autoantibodies titers, blood counts, proteinuria, kidney histology, neurocognitive functions (novel object recognition, staircase, Y-maze and the forced swimming tests) and brain histology.Immunization with HBVv induced acceleration of kidney disease manifested by high anti-dsDNA antibodies (. p less than 0.01), early onset of proteinuria (. p less than 0.05), histological damage and deposition of HBs antigen in the kidney. Mice immunized with HBVv and/or alum had decreased cells counts mainly of the red cell lineage (. p less than 0.001), memory deficits (. p less than 0.01), and increased activated microglia in different areas of the brain compare with mice immunized with PBS. Anxiety-like behavior was more pronounced among mice immunized with alum.In conclusion, herein we report that immunization with the HBVv aggravated kidney disease in an animal model of SLE. Immunization with either HBVv or alum affected blood counts, neurocognitive functions and brain gliosis. Our data support the concept that different component of vaccines may be linked with immune and autoimmune mediated adverse events. © 2014 Elsevier Ltd. |
publishDate |
2014 |
dc.date.created.spa.fl_str_mv |
2014 |
dc.date.accessioned.none.fl_str_mv |
2020-05-25T23:55:54Z |
dc.date.available.none.fl_str_mv |
2020-05-25T23:55:54Z |
dc.type.eng.fl_str_mv |
article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.spa.spa.fl_str_mv |
Artículo |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.1016/j.jaut.2014.06.006 |
dc.identifier.issn.none.fl_str_mv |
10959157 08968411 |
dc.identifier.uri.none.fl_str_mv |
https://repository.urosario.edu.co/handle/10336/22257 |
url |
https://doi.org/10.1016/j.jaut.2014.06.006 https://repository.urosario.edu.co/handle/10336/22257 |
identifier_str_mv |
10959157 08968411 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.citationEndPage.none.fl_str_mv |
32 |
dc.relation.citationStartPage.none.fl_str_mv |
21 |
dc.relation.citationTitle.none.fl_str_mv |
Journal of Autoimmunity |
dc.relation.citationVolume.none.fl_str_mv |
Vol. 54 |
dc.relation.ispartof.spa.fl_str_mv |
Journal of Autoimmunity, ISSN:10959157, 08968411, Vol.54,(2014); pp. 21-32 |
dc.relation.uri.spa.fl_str_mv |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908495912&doi=10.1016%2fj.jaut.2014.06.006&partnerID=40&md5=2a3f8b48bb27518b4b8aafa4b2bb95b2 |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.acceso.spa.fl_str_mv |
Abierto (Texto Completo) |
rights_invalid_str_mv |
Abierto (Texto Completo) http://purl.org/coar/access_right/c_abf2 |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Academic Press |
institution |
Universidad del Rosario |
dc.source.instname.spa.fl_str_mv |
instname:Universidad del Rosario |
dc.source.reponame.spa.fl_str_mv |
reponame:Repositorio Institucional EdocUR |
bitstream.url.fl_str_mv |
https://repository.urosario.edu.co/bitstreams/434ccff5-f697-4733-b8f3-37edbd00114e/download https://repository.urosario.edu.co/bitstreams/87c66292-6a54-42d8-b348-4c0a8eed2baf/download https://repository.urosario.edu.co/bitstreams/b0a422c4-8591-4ad1-84e4-2f340b349490/download |
bitstream.checksum.fl_str_mv |
6c549dc8444335e00e79c4bd7ad50167 dfa8ed665f21466a31137735ff30477c 94f21b4177cf25ca0299c61e8a65b0a5 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio institucional EdocUR |
repository.mail.fl_str_mv |
edocur@urosario.edu.co |
_version_ |
1814167501819346944 |
spelling |
751e2509-f1ab-4892-a16a-b8c59144709b-13b0a0171-7a9a-42f7-9109-3d1be6eff9ad-1abf6d844-0cd0-41c4-b93d-0d7323499104-1f1706d96-2326-4dea-b737-d02d6be9df9a-18fe9565a-c540-4d90-847c-0015844b64f0-1c8824fac-5fca-48bd-acff-0f2116edaaa7-10e5c68ec-93ba-4a0b-b16f-12e9ffa2b6a1-1cbec897c-f6af-48a4-a114-7c00358fab83-1c025b862-c7b0-4985-9431-ef9e2f562831-1b6ececbc-d25e-4c58-a7d9-a058a1533d39-1ef6fa7cf-59f5-4c86-bc53-d389160d7ddf-12020-05-25T23:55:54Z2020-05-25T23:55:54Z2014Hepatitis-B vaccine (HBVv) can prevent HBV-infection and associated liver diseases. However, concerns regarding its safety, particularly among patients with autoimmune diseases (i.e. SLE) were raised. Moreover, the aluminum adjuvant in HBVv was related to immune mediated adverse events. Therefore, we examined the effects of immunization with HBVv or alum on SLE-like disease in a murine model.NZBWF1 mice were immunized with HBVv (Engerix), or aluminum hydroxide (alum) or phosphate buffered saline (PBS) at 8 and 12 weeks of age. Mice were followed for weight, autoantibodies titers, blood counts, proteinuria, kidney histology, neurocognitive functions (novel object recognition, staircase, Y-maze and the forced swimming tests) and brain histology.Immunization with HBVv induced acceleration of kidney disease manifested by high anti-dsDNA antibodies (. p less than 0.01), early onset of proteinuria (. p less than 0.05), histological damage and deposition of HBs antigen in the kidney. Mice immunized with HBVv and/or alum had decreased cells counts mainly of the red cell lineage (. p less than 0.001), memory deficits (. p less than 0.01), and increased activated microglia in different areas of the brain compare with mice immunized with PBS. Anxiety-like behavior was more pronounced among mice immunized with alum.In conclusion, herein we report that immunization with the HBVv aggravated kidney disease in an animal model of SLE. Immunization with either HBVv or alum affected blood counts, neurocognitive functions and brain gliosis. Our data support the concept that different component of vaccines may be linked with immune and autoimmune mediated adverse events. © 2014 Elsevier Ltd.application/pdfhttps://doi.org/10.1016/j.jaut.2014.06.0061095915708968411https://repository.urosario.edu.co/handle/10336/22257engAcademic Press3221Journal of AutoimmunityVol. 54Journal of Autoimmunity, ISSN:10959157, 08968411, Vol.54,(2014); pp. 21-32https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908495912&doi=10.1016%2fj.jaut.2014.06.006&partnerID=40&md5=2a3f8b48bb27518b4b8aafa4b2bb95b2Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURAluminum hydroxideDouble stranded dna antibodyHepatitis b surface antigenImmunological adjuvantPhosphate buffered salineRecombinant hepatitis b vaccineAntinuclear antibodyHepatitis b vaccineAnimal experimentAnimal modelAnimal tissueAntibody titerAnxietyArticleAutoimmune diseaseBlood cell countBrain histologyBrain regionCell lineageCognitionControlled studyDisease exacerbationDrug safetyErythrocyteFemaleForced swim testGliosisImmunizationKidney diseaseLupus like syndromeMemory disorderMicrogliaMouseNonhumanNovel object recognition testProteinuriaStaircase testSystemic lupus erythematosusY-maze testAnimalBrainDisease modelDrug effectsImmunologyLupus erythematosus nephritisPathologyPathophysiologyAnimalsBrainCognitionFemaleHepatitis b vaccinesLupus nephritisMiceProteinuriaAutoimmune/autoinflammatory syndrome induced by adjuvant (asia)AutoimmunityHepatitis b vaccineNeuro-cognitive testsSleVaccinationanimalantinuclearAntibodiesDisease modelsImmunization with hepatitis B vaccine accelerates SLE-like disease in a murine modelarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Agmon-Levin, NancyArango, María-TeresaKivity, ShayeKatzav, AvivaGilburd, BorisBlank, MiriTomer, NirVolkov, AlexBarshack, IrisChapman, JoabShoenfeld, YehudaORIGINAL1-s2-0-S0896841114001036-main.pdfapplication/pdf1937855https://repository.urosario.edu.co/bitstreams/434ccff5-f697-4733-b8f3-37edbd00114e/download6c549dc8444335e00e79c4bd7ad50167MD51TEXT1-s2-0-S0896841114001036-main.pdf.txt1-s2-0-S0896841114001036-main.pdf.txtExtracted texttext/plain64089https://repository.urosario.edu.co/bitstreams/87c66292-6a54-42d8-b348-4c0a8eed2baf/downloaddfa8ed665f21466a31137735ff30477cMD52THUMBNAIL1-s2-0-S0896841114001036-main.pdf.jpg1-s2-0-S0896841114001036-main.pdf.jpgGenerated Thumbnailimage/jpeg4699https://repository.urosario.edu.co/bitstreams/b0a422c4-8591-4ad1-84e4-2f340b349490/download94f21b4177cf25ca0299c61e8a65b0a5MD5310336/22257oai:repository.urosario.edu.co:10336/222572022-05-02 07:37:20.307885https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co |